|
NEWS:
DECEMBER 2005
Press
Release:
Guava Technologies
have introduced Caspase 3/7 and 8 Assay kits enabling rapid and
sensitive detection of the initial and mid-stages of programmed
cell death. To
read press release click
here.
FDA approves Chiron's West
Nile test. To
read article click
here.
FDA
releases warning on Amgen Inc.'s anemia drugs Aransep and Epogen.
To
read article click
here.
-12/01/2005-
Lexicon
Genetics Inc.
and Genetech Inc. expand research collaboration. To
read article click
here.
Rigel
Pharmaceuticals' drug R112 found to be largely ineffective in the
treatment of allergic rhinitis. To
read article click
here.
|